Stock Analysis on Net
Stock Analysis on Net

AbbVie Inc. (NYSE:ABBV)

$24.99

Common-Size Income Statement

Paying user area

Try for free

AbbVie Inc. pages available for free this week:

The data is hidden behind: . Unhide it.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

AbbVie Inc., common-size consolidated income statement

Microsoft Excel
12 months ended: Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Net revenues
Cost of products sold
Gross margin
Selling, general and administrative
Research and development
Acquired IPR&D and milestones
Other operating income (expense), net
Operating earnings
Interest expense
Interest income
Interest expense, net
Net foreign exchange loss
Other expense, net
Earnings before income tax expense
Income tax (expense) benefit
Net earnings
Net earnings attributable to noncontrolling interest
Net earnings attributable to AbbVie Inc.

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

Income statement item Description The company
Operating earnings The net result for the period of deducting operating expenses from operating revenues. AbbVie Inc. operating earnings as a percentage of net revenues decreased from 2022 to 2023 and from 2023 to 2024.
Earnings before income tax expense Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. AbbVie Inc. earnings before income tax expense as a percentage of net revenues decreased from 2022 to 2023 and from 2023 to 2024.
Net earnings attributable to AbbVie Inc. The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. AbbVie Inc. net earnings attributable to AbbVie Inc. as a percentage of net revenues decreased from 2022 to 2023 and from 2023 to 2024.